Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2005
11/24/2005CA2852855A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/24/2005CA2837792A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/24/2005CA2826522A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/24/2005CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy
11/24/2005CA2816163A1 Methods and kits to detect hereditary angioedema type iii
11/24/2005CA2566257A1 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
11/24/2005CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme
11/24/2005CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy
11/24/2005CA2560108A1 Immunostimulatory nucleic acids for inducing il-10 responses
11/23/2005EP1597383A2 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
11/23/2005EP1597351A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
11/23/2005EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
11/23/2005EP1597319A1 Monofunctionalized perylenetetracarboxylic acid bisimides
11/23/2005EP1596813A2 Lung-expressed polypeptides
11/23/2005EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1
11/23/2005EP1468112A4 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
11/23/2005EP1421201A4 Methods for immobilizing molecules to a solid phase and uses thereof
11/23/2005EP1341932A4 Improved methods for gene expression monitoring on electronic microarrays
11/23/2005EP1112281B1 Pteridine nucleotide analogs
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005EP0662128B1 Methods and compositions for controlling translation of hcv proteins
11/23/2005CN1701120A Nucleic acid constructs for gene expression
11/23/2005CN1701077A Use of antisense oligonucleotides to inhibit the expression of Akt-1
11/23/2005CN1699394A CpG-N ODN gene sequence with high immunological activity CpG-S ODN and antagonism CpG-N ODN and use thereof
11/22/2005US6967262 A polynucleotide containing a nucleotide sequence encoding a polypeptide having galactinol synthase activity
11/22/2005US6967247 Deprotection of phosphorus in oligonucleotide synthesis
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005US6967078 nuclear transcriptional regulation following BMP signal transduction; screening for a compound that disrupts transcriptional repression of a gene
11/22/2005US6967076 A reporter sequence consists of a reporter gene whose expression is regulated by a protein specific to HIV viruses, expressed from a genome of an HIV virus upon infection of a cell tranduced by genetic engineered viral vector
11/22/2005US6967019 Production of pancreatic islet cells and delivery of insulin
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108611A2 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis
11/17/2005WO2005108610A2 Methods for the selection of subjects for multiple sclerosis therapy
11/17/2005WO2005108579A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005WO2005108578A1 Polynucleotides for the detection of escherichia coli
11/17/2005WO2005108428A2 Cd40 splice variants and their uses
11/17/2005WO2005108415A2 Membrane associated molecules
11/17/2005WO2005108411A2 Substituted pixyl protecting groups for oligonucleotide synthesis
11/17/2005WO2005060553A3 Geraniol synthase, methods of production and uses thereof
11/17/2005WO2005049648A3 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
11/17/2005WO2005046622A3 Custom vectors for treating and preventing pancreatic cancer
11/17/2005WO2005037988A3 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
11/17/2005WO2005021577A3 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
11/17/2005WO2005021044A3 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
11/17/2005WO2005016874A3 Crown ether derivatives
11/17/2005WO2005001141A3 Methods and nucleic acids for analyses of colorectal cell proliferative disorders
11/17/2005WO2005000234A3 Novel coronavirus inhibitors
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2004070006A3 Nucleic acid antigens embedded in thermoplastic
11/17/2005WO2004024087A3 Methods of diagnosing and treating hyperproliferative disorders
11/17/2005US20050257289 AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use
11/17/2005US20050257285 Compositions and methods for the treatment of Pierce's disease
11/17/2005US20050257282 Plant centromere compositions
11/17/2005US20050256525 Dilation introducer for orthopedic surgery
11/17/2005US20050256283 Monomers containing polyoxyalkylenes and polymer supports therefrom
11/17/2005US20050256075 Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
11/17/2005US20050256072 Dual functional oligonucleotides for use in repressing mutant gene expression
11/17/2005US20050256071 Inhibitor nucleic acids
11/17/2005US20050256069 IRNA agents with biocleavable tethers
11/17/2005US20050256068 Moderator of gene expression; using small nucleic acids
11/17/2005US20050256052 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes
11/17/2005US20050256050 Vascular endothelial growth factor 2
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256041 polypeptides, polynucleotides encoding the polypeptides and antibodies, for detecting ligands, as well as agonists and antagonists, modulation of tumor growth, metastasis and immunology
11/17/2005US20050256039 Novel fibroblast growth factors and methods of use thereof
11/17/2005US20050255560 Ztnf11, a tumor necrosis factor
11/17/2005US20050255555 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy
11/17/2005US20050255553 Mage C2 antigenic peptides and uses thereof
11/17/2005US20050255551 Methods and compositions relating to chimeric nicotinic receptor subunits
11/17/2005US20050255548 Protein scaffolds for antibody mimics and other binding proteins
11/17/2005US20050255547 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same
11/17/2005US20050255546 DNA coding for a polypeptide; a polymer conjugated drug with increased stability of the protein in vivo; stimulating the production of erythrocyte progenitor cells in culture in the presence of the polypeptide, or in vivo
11/17/2005US20050255545 Regulation of human hematopoietin receptor-like protein
11/17/2005US20050255532 Antibodies that immunospecifically bind to B lymphocyte stimulator
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255530 Identification and isolation of pluripotency determining factors
11/17/2005US20050255520 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); specifically binds to polypeptide encoded by nucleic acid; labeled or conjugated to therapeutic agent; treatment of cardiovascular disorders
11/17/2005US20050255516 Method for quantitative analysis of a nucleic acid amplification reaction
11/17/2005US20050255499 Process for discrimination of nucleic acid sequence variants
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255491 Small molecule and peptide arrays and uses thereof
11/17/2005US20050255489 nucleotide sequence encoding a polypeptide having N-acetylglucosaminyl transferase V activity called Vb, useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation
11/17/2005US20050255487 Methods and compositions for selecting siRNA of improved functionality
11/17/2005US20050255403 exposure to UV/VIS radiation, by the action of electromagnetic radiation to modify the nucleotide; for preparing DNA chips
11/17/2005US20050255123 Chimeric ebola virus envelopes and uses therefor
11/17/2005US20050255094 Mitogen-activated protein kinase kinase MEK6 and methods of use therefor
11/17/2005US20050255087 Adeno-associated virus vectors
11/17/2005US20050255086 Adeno-associated viral vector comprising short interfering RNA for use in the treatment of nervous system disorders; tissue engineering and gene therapy; tissue targeted therapy
11/17/2005DE10393431T5 Mikroarrays mit mehreren Oligonukleotiden in einzelnen Array Features Microarrays with multiple oligonucleotides in each array features
11/17/2005CA2569085A1 Polynucleotides for the detection of escherichia coli
11/17/2005CA2566418A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005CA2563367A1 Novel compositions and methods in cancer
11/17/2005CA2563168A1 Nucleic-acid programmable protein arrays
11/17/2005CA2561901A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
11/16/2005EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides
11/16/2005EP1595547A2 Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594982A2 Methods and compositions for rna detection and quantitation
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 899